Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frohlich

Showing results (1191-1200 of 1,208) with videos related to

Pageof 121
Sort By:
Brain Stimulation|March 9, 2026
Dose-Response Relationships in Transcranial Brain Stimulation: Physics, Physiology and MechanismGhazaleh Soleimani, Ivan Alekseichuk, Christian Aurup, et al.
Global Heart|February 11, 2015
Why did ancient people have atherosclerosis?: from autopsies to computed tomography to potential causesGregory S Thomas, L Samuel Wann, Adel H Allam, et al.
Journal of Internal Medicine|February 16, 2006
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panelP J Barter, C M Ballantyne, R Carmena, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2001
BMS-196085: a potent and selective full agonist of the human beta(3) adrenergic receptorA V Gavai, P M Sher, A B Mikkilineni, et al.
Global Change Biology|January 14, 2020
Invasive non-native species likely to threaten biodiversity and ecosystems in the Antarctic Peninsula regionKevin A Hughes, Oliver L Pescott, Jodey Peyton, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
BMS-201620: a selective beta 3 agonistW N Washburn, C-Q Sun, G Bisacchi, et al.
JMIR Research Protocols|May 31, 2017
Diagnosis, Prevalence, Awareness, Treatment, Prevention, and Control of Hypertension in Cameroon: Protocol for a Systematic Review and Meta-Analysis of Clinic-Based and Community-Based StudiesBarthelemy Kuate Defo, Jean Claude Mbanya, Jean-Claude Tardif, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2001
Beta 3 agonists. Part 1: evolution from inception to BMS-194449W N Washburn, P M Sher, K M Poss, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2022
Stone Age <i>Yersinia pestis</i> genomes shed light on the early evolution, diversity, and ecology of plagueAida Andrades Valtueña, Gunnar U Neumann, Maria A Spyrou, et al.
Gut|March 9, 2011
Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and NutritionFränzel J B van Duijnhoven, H Bas Bueno-De-Mesquita, Miriam Calligaro, et al.
Pageof 121

Showing results (1191-1200 of 1,208) with videos related to

Sort By:
Pageof 121
Brain Stimulation|March 9, 2026
Dose-Response Relationships in Transcranial Brain Stimulation: Physics, Physiology and MechanismGhazaleh Soleimani, Ivan Alekseichuk, Christian Aurup, et al.
Global Heart|February 11, 2015
Why did ancient people have atherosclerosis?: from autopsies to computed tomography to potential causesGregory S Thomas, L Samuel Wann, Adel H Allam, et al.
Journal of Internal Medicine|February 16, 2006
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panelP J Barter, C M Ballantyne, R Carmena, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2001
BMS-196085: a potent and selective full agonist of the human beta(3) adrenergic receptorA V Gavai, P M Sher, A B Mikkilineni, et al.
Global Change Biology|January 14, 2020
Invasive non-native species likely to threaten biodiversity and ecosystems in the Antarctic Peninsula regionKevin A Hughes, Oliver L Pescott, Jodey Peyton, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
BMS-201620: a selective beta 3 agonistW N Washburn, C-Q Sun, G Bisacchi, et al.
JMIR Research Protocols|May 31, 2017
Diagnosis, Prevalence, Awareness, Treatment, Prevention, and Control of Hypertension in Cameroon: Protocol for a Systematic Review and Meta-Analysis of Clinic-Based and Community-Based StudiesBarthelemy Kuate Defo, Jean Claude Mbanya, Jean-Claude Tardif, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2001
Beta 3 agonists. Part 1: evolution from inception to BMS-194449W N Washburn, P M Sher, K M Poss, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2022
Stone Age <i>Yersinia pestis</i> genomes shed light on the early evolution, diversity, and ecology of plagueAida Andrades Valtueña, Gunnar U Neumann, Maria A Spyrou, et al.
Gut|March 9, 2011
Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and NutritionFränzel J B van Duijnhoven, H Bas Bueno-De-Mesquita, Miriam Calligaro, et al.
Pageof 121